help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krozowski, Z.
Right arrow Articles by Andrews, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krozowski, Z.
Right arrow Articles by Andrews, R. K.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 2203-2209, Copyright © 1995 by Endocrine Society

ARTICLES

Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta

Z Krozowski, JA MaGuire, AN Stein-Oakley, J Dowling, RE Smith and RK Andrews
Laboratory of Molecular Hypertension, Baker Institute of Medical Research, Prahran, Australia.

It has been proposed that the inactivation of glucocorticoids by the enzyme 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) is an obligatory step in the kidney, permitting binding of aldosterone to the mineralocorticoid receptor, and in the placenta, protecting the fetus from high circulating levels of maternal glucocorticoids. Both low and high affinity isoforms of 11 beta HSD are known to exist, with evidence accumulating that the former species (11 beta HSD1) does not fulfill criteria that would allow it to perform these physiological functions. We have recently cloned a high affinity isoform of the enzyme (11 beta HSD2) from a human kidney library and have shown this species to possess all of the characteristics predicted from whole cell studies. In the present study we have raised a polyclonal antibody (HUH23) to a synthetic peptide deduced from the carboxy-terminus of the protein. The immunopurified antibody recognized a single band at 41,000 daltons on Western blots of mammalian cells transfected with an expression plasmid containing 11 beta HSD2, slightly smaller than the predicted 44,140 daltons protein. A single band of identical size was also seen in blots of human kidney and placenta, suggesting post-translational processing of the enzyme. Immunohistochemical studies on frozen sections of human kidney showed strong 11 beta HSD2 immunoreactivity in the cortical distal convoluted tubules and collecting ducts. Strong staining was also observed in medullary tubules, which had the appearance of collecting ducts and the thick ascending limb of Henle's loop. Staining of medium intensity was observed in vascular smooth muscle cells. Epithelial cells of glomeruli showed weak but detectable reactivity with HUH23. In the placenta, HUH23 antibody immunoreactivity was restricted to syncytial trophoblast cells in which strong staining was observed. These results suggest that the 11 beta HSD2 enzyme colocalizes with the mineralocorticoid receptor in the distal nephron where it allows aldosterone to occupy its physiological receptor. Furthermore, 11 beta HSD2 is also ideally situated in the placenta to protect the fetus from high circulating levels of maternal glucocorticoids.


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
A. E. Michael and A. T. Papageorghiou
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Hum. Reprod. Update, June 13, 2008; (2008) dmn021v1.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. Sato, H. Chisaka, K. Okamura, and J. R.G. Challis
Effect of the Interaction Between Lipoxygenase Pathway and Progesterone on the Regulation of Hydroxysteroid 11-Beta Dehydrogenase 2 in Cultured Human Term Placental Trophoblasts
Biol Reprod, March 1, 2008; 78(3): 514 - 520.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Jang, V. R. Obeyesekere, R. J. Dilley, Z. Krozowski, W. J. Inder, and F. P. Alford
Altered Activity of 11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2 in Skeletal Muscle Confers Metabolic Protection in Subjects with Type 2 Diabetes
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3314 - 3320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Usa, R. J. Singh, B. C. Netzel, Y. Liu, H. Raff, and M. Liang
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F186 - F192.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. W. Good
Nongenomic Actions of Aldosterone on the Renal Tubule
Hypertension, April 1, 2007; 49(4): 728 - 739.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Naray-Fejes-Toth and G. Fejes-Toth
Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F486 - F494.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Nakamura, S. Suzuki, T. Suzuki, K. Ono, I. Miura, F. Satoh, T. Moriya, H. Saito, S. Yamada, S. Ito, et al.
MDM2: A Novel Mineralocorticoid-Responsive Gene Involved in Aldosterone-Induced Human Vascular Structural Remodeling
Am. J. Pathol., August 1, 2006; 169(2): 362 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton
Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev., April 1, 2006; 27(2): 141 - 169.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
L. Myatt
Placental adaptive responses and fetal programming
J. Physiol., April 1, 2006; 572(1): 25 - 30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. R. Garbrecht, T. J. Schmidt, Z. S. Krozowski, and J. M. Snyder
11beta-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites
Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E653 - E660.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. Yang, L. Julan, F. Rubio, A. Sharma, and H. Guan
Cadmium reduces 11{beta}-hydroxysteroid dehydrogenase type 2 activity and expression in human placental trophoblast cells
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E135 - E142.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
N. Draper and P. M Stewart
11{beta}-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
J. Endocrinol., August 1, 2005; 186(2): 251 - 271.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
H. Chisaka, J. F. Johnstone, M. Premyslova, Z. Manduch, and J. R.G. Challis
Effect of Pro-inflammatory Cytokines on Expression and Activity of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Term Placental Trophoblast and Human Choriocarcinoma JEG-3 Cells
Reproductive Sciences, July 1, 2005; 12(5): 303 - 309.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
J. F. Johnstone, A. D. Bocking, E. Unlugedik, and J. R.G. Challis
The Effects of Chorioamnionitis and Betamethasone on 11{beta}, Hydroxysteroid Dehydrogenase Types 1 and 2 and the Glucocorticoid Receptor in Preterm Human Placenta
Reproductive Sciences, May 1, 2005; 12(4): 238 - 245.
[Abstract] [PDF]

Home page
 EndocrinologyHome page
L. Julan, H. Guan, J. P. van Beek, and K. Yang
Peroxisome Proliferator-Activated Receptor {delta} Suppresses 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene Expression in Human Placental Trophoblast Cells
Endocrinology, March 1, 2005; 146(3): 1482 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. P. van Beek, H. Guan, L. Julan, and K. Yang
Glucocorticoids Stimulate the Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Cultured Human Placental Trophoblast Cells
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5614 - 5621.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. Tomlinson, E. A. Walker, I. J. Bujalska, N. Draper, G. G. Lavery, M. S. Cooper, M. Hewison, and P. M. Stewart
11{beta}-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response
Endocr. Rev., October 1, 2004; 25(5): 831 - 866.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. A. Head, V. R. Obeyesekere, M. E. Jones, E. R. Simpson, and Z. S. Krozowski
Aromatase-Deficient (ArKO) Mice Have Reduced Blood Pressure and Baroreflex Sensitivity
Endocrinology, September 1, 2004; 145(9): 4286 - 4291.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
S McMullen, J C Osgerby, L M Thurston, T S Gadd, P J Wood, D C Wathes, and A E Michael
Alterations in placental 11{beta}-hydroxysteroid dehydrogenase (11{beta}HSD) activities and fetal cortisol:cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation in ewes
Reproduction, June 1, 2004; 127(6): 717 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Lin-Su, P. Zhou, N. Arora, B. P. Betensky, M. I. New, and R. C. Wilson
In Vitro Expression Studies of a Novel Mutation {Delta}299 in a Patient Affected with Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2024 - 2027.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Alfaidy, W. Li, T. MacIntosh, K. Yang, and J. Challis
Late Gestation Increase in 11{beta}-Hydroxysteroid Dehydrogenase 1 Expression in Human Fetal Membranes: A Novel Intrauterine Source of Cortisol
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 5033 - 5038.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Z. Chai, P. Brereton, T. Suzuki, H. Sasano, V. Obeyesekere, G. Escher, R. Saffery, P. Fuller, C. Enriquez, and Z. Krozowski
17{beta}-Hydroxysteroid Dehydrogenase Type XI Localizes to Human Steroidogenic Cells
Endocrinology, May 1, 2003; 144(5): 2084 - 2091.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski
Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Mune, H. Morita, T. Suzuki, Y. Takahashi, Y. Isomura, T. Tanahashi, H. Daido, N. Yamakita, T. Deguchi, H. Sasano, et al.
Role of Local 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Determining the Phenotype of Adrenal Adenomas
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 864 - 870.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Diederich, E. Eigendorff, P. Burkhardt, M. Quinkler, C. Bumke-Vogt, M. Rochel, D. Seidelmann, P. Esperling, W. Oelkers, and V. Bahr
11{beta}-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5695 - 5701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Alfaidy, S. Gupta, C. DeMarco, I. Caniggia, and J. R. G. Challis
Oxygen Regulation of Placental 11{beta}-Hydroxysteroid Dehydrogenase 2: Physiological and Pathological Implications
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4797 - 4805.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P. Ferrari, M. G. Bianchetti, A. Sansonnens, and F. J. Frey
Modulation of Renal Calcium Handling by 11{beta}-Hydroxysteroid Dehydrogenase Type 2
J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2540 - 2546.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. B. Hardy and K. Yang
The Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Is Induced during Trophoblast Differentiation: Effects of Hypoxia
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3696 - 3701.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. E. Murphy, T. Zakar, R. Smith, W. B. Giles, P. G. Gibson, and V. L. Clifton
Reduced 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Activity Is Associated with Decreased Birth Weight Centile in Pregnancies Complicated by Asthma
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1660 - 1668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. E. ORSIDA, Z. S. KROZOWSKI, and E. H. WALTERS
Clinical Relevance of Airway 11beta -Hydroxysteroid Dehydrogenase Type II Enzyme in Asthma
Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 1010 - 1014.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kataoka, A. Kudo, H. Hirano, H. Kawakami, T. Kawano, E. Higashihara, H. Tanaka, F. Delarue, J.-D. Sraer, T. Mune, et al.
11{beta}-Hydroxysteroid Dehydrogenase Type 2 Is Expressed in the Human Kidney Glomerulus
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 877 - 882.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
L.-L. HSIAO, F. DANGOND, T. YOSHIDA, R. HONG, R. V. JENSEN, J. MISRA, W. DILLON, K. F. LEE, K. E. CLARK, P. HAVERTY, et al.
A compendium of gene expression in normal human tissues
Physiol Genomics, December 21, 2001; 7(2): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Sarkar, S.-W. Tsai, T. T. Nguyen, M. Plevyak, J. F. Padbury, and L. P. Rubin
Inhibition of placental 11beta -hydroxysteroid dehydrogenase type 2 by catecholamines via alpha -adrenergic signaling
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1966 - R1974.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Ferrari, A. Sansonnens, B. Dick, and F. J. Frey
In Vivo 11{beta}-HSD-2 Activity: Variability, Salt-Sensitivity, and Effect of Licorice
Hypertension, December 1, 2001; 38(6): 1330 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Alfaidy, Z. G. Xiong, L. Myatt, Stephen. J. Lye, J. F. MacDonald, and J. R. G. Challis
Prostaglandin F2{alpha} Potentiates Cortisol Production by Stimulating 11{beta}-Hydroxysteroid Dehydrogenase 1: A Novel Feedback Loop That May Contribute to Human Labor
J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5585 - 5592.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Schoof, M. Girstl, W. Frobenius, M. Kirschbaum, H. G. Dörr, W. Rascher, and J. Dötsch
Decreased Gene Expression of 11{beta}-Hydroxysteroid Dehydrogenase Type 2 and 15-Hydroxyprostaglandin Dehydrogenase in Human Placenta of Patients with Preeclampsia
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1313 - 1317.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Renal Physiol.Home page
N. Farman and M.-E. Rafestin-Oblin
Multiple aspects of mineralocorticoid selectivity
Am J Physiol Renal Physiol, February 1, 2001; 280(2): F181 - F192.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Hirasawa, J. Takeyama, H. Sasano, K. Fukushima, T. Suzuki, Y. Muramatu, A. D. Darnel, C. Kaneko, N. Hiwatashi, T. Toyota, et al.
11{beta}-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Placenta
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1306 - 1309.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. I. New and R. C. Wilson
Steroid disorders in children: Congenital adrenal hyperplasia and apparent mineralocorticoid excess
PNAS, October 26, 1999; 96(22): 12790 - 12797.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Kato, H. Sasano, S. Ohara, H. Sekine, S. Mochizuki, T. Mune, K. Yasuda, H. Nagura, T. Shimosegawa, T. Toyota, et al.
Coexpression of Mineralocorticoid Receptors and 11{beta}-Hydroxysteroid Dehydrogenase 2 in Human Gastric Mucosa
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2568 - 2573.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
D.B. Hardy, L.E. Pereria, and K. Yang
Prostaglandins and Leukotriene B4 Are Potent Inhibitors of 11ß-Hydroxysteroid Dehydrogenase Type 2 Activity in Human Choriocarcinoma JEG-3 Cells
Biol Reprod, July 1, 1999; 61(1): 40 - 45.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Hirasawa, H. Sasano, T. Suzuki, J. Takeyama, Y. Muramatu, K. Fukushima, N. Hiwatashi, T. Toyota, H. Nagura, and Z. S. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type 2 and Mineralocorticoid Receptor in Human Fetal Development
J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1453 - 1458.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
J. Tremblay, D.B. Hardy, L.E. Pereira, and K. Yang
Retinoic Acid Stimulates the Expression of 11ß-Hydroxysteroid Dehydrogenase Type 2 in Human Choriocarcinoma JEG-3 Cells
Biol Reprod, March 1, 1999; 60(3): 541 - 545.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. A. Patel, K. Sun, and J. R. G. Challis
Local Modulation by 11{beta}-Hydroxysteroid Dehydrogenase of Glucocorticoid Effects on the Activity of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion and Placental Trophoblast Cells
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 395 - 400.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
P. J. Burton and B. J. Waddell
Dual Function of 11ß-Hydroxysteroid Dehydrogenase in Placenta: Modulating Placental Glucocorticoid Passage and Local Steroid Action
Biol Reprod, February 1, 1999; 60(2): 234 - 240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Rogoff, Z. Smolenicka, I. Bergadá, G. Vallejo, M. Barontini, J. J. Heinrich, and P. Ferrari
The Codon 213 of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene Is a Hot Spot for Mutations in Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4391 - 4393.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
R. Sampath-Kumar, S.G. Matthews, and K. Yang
11ß-Hydroxysteroid Dehydrogenase Type 2 Is the Predominant Isozyme in the Guinea Pig Placenta: Decreases in Messenger Ribonucleic Acid and Activity at Term
Biol Reprod, December 1, 1998; 59(6): 1378 - 1384.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Suzuki, H. Sasano, S. Suzuki, G. Hirasawa, J. Takeyama, Y. Muramatsu, F. Date, H. Nagura, and Z. S. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Lung: Possible Regulator of Mineralocorticoid Action
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4022 - 4025.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. C. Wilson, S. Dave-Sharma, J.-Q. Wei, V. R. Obeyesekere, K. Li, P. Ferrari, Z. S. Krozowski, C. H. L. Shackleton, L. Bradlow, T. Wiens, et al.
A genetic defect resulting in mild low-renin hypertension
PNAS, August 18, 1998; 95(17): 10200 - 10205.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Dave-Sharma, R. C. Wilson, M. D. Harbison, R. Newfield, M. R. Azar, Z. S. Krozowski, J. W. Funder, C. H. L. Shackleton, H. L. Bradlow, J.-Q. Wei, et al.
Examination of Genotype and Phenotype Relationships in 14 Patients with Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2244 - 2254.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
A. Naray-Fejes-Toth and G. Fejes-Toth
Extranuclear Localization of Endogenous 11{beta}-Hydroxysteroid Dehydrogenase-2 in Aldosterone Target Cells
Endocrinology, June 1, 1998; 139(6): 2955 - 2959.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. H.M. van Uum, A. R.M.M. Hermus, P. Smits, T. Thien, and J. W.M. Lenders
The role of 11{beta}-hydroxysteroid dehydrogenase in the pathogenesis of hypertension
Cardiovasc Res, April 1, 1998; 38(1): 16 - 24.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. S. Brem, R. B. Bina, T. C. King, and D. J. Morris
Localization of 2 11{beta}-OH Steroid Dehydrogenase Isoforms in Aortic Endothelial Cells
Hypertension, January 1, 1998; 31(1): 459 - 462.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kitanaka, N. Katsumata, A. Tanae, I. Hibi, K.-I. Takeyama, H. Fuse, S. Kato, and T. Tanaka
A New Compound Heterozygous Mutation in the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Gene in a Case of Apparent Mineralocorticoid Excess
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4054 - 4058.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. E. Smith, L. A. Salamonsen, P. A. Komesaroff, K. X. Z. Li, K. M. Myles, M. Lawrence, and Z. Krozowski
11{beta}-Hydroxysteroid Dehydrogenase Type II in the Human Endometrium: Localization and Activity during the Menstrual Cycle
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4252 - 4257.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Hirasawa, H. Sasano, K.-i. Takahashi, K. Fukushima, T. Suzuki, N. Hiwatashi, T. Toyota, Z. S. Krozowski, and H. Nagura
Colocalization of 11{beta}-Hydroxysteroid Dehydrogenase Type II and Mineralocorticoid Receptor in Human Epithelia
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3859 - 3863.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Sun, K. Yang, and J. R. G. Challis
Differential Regulation of 11 {beta}-Hydroxysteroid Dehydrogenase Type 1 and 2 by Nitric Oxide in Cultured Human Placental Trophoblast and Chorionic Cell Preparation
Endocrinology, November 1, 1997; 138(11): 4912 - 4920.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
G. Escher, I. Galli, B. S. Vishwanath, B. M. Frey, and F. J. Frey
Tumor Necrosis Factor alpha  and Interleukin 1beta Enhance the Cortisone/Cortisol Shuttle
J. Exp. Med., July 21, 1997; 186(2): 189 - 198.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. X. Z. Li, V. R. Obeyesekere, Z. S. Krozowski, and P. Ferrari
Oxoreductase and Dehydrogenase Activities of the Human and Rat 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Enzyme
Endocrinology, July 1, 1997; 138(7): 2948 - 2952.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
J. Bissonnette, S. Chambe